Mizokami A - Search Results

1

Variations in photodynamic diagnosis for bladder cancer due to the quality of endoscopic equipment.

Nohara T, Kamijima T, Fukuda R, Kano H, Shimada T, Nakano T, Kato Y, Kadomoto S, Iwamoto H, Yaegashi H, Iijima M, Kawaguchi S, Shigehara K, Izumi K, Kadono Y, Mizokami A. Nohara T, et al. Among authors: mizokami a. Photodiagnosis Photodyn Ther. 2022 Mar;37:102628. doi: 10.1016/j.pdpdt.2021.102628. Epub 2021 Nov 19. Photodiagnosis Photodyn Ther. 2022. PMID: 34808397

2

Four year clinical statistics of iridium-192 high dose rate brachytherapy.

Shigehara K, Mizokami A, Komatsu K, Koshida K, Namiki M. Shigehara K, et al. Among authors: mizokami a. Int J Urol. 2006 Feb;13(2):116-21. doi: 10.1111/j.1442-2042.2006.01243.x. Int J Urol. 2006. PMID: 16563134 Free article. Clinical Trial.

3

Risedronate recovers bone loss in patients with prostate cancer undergoing androgen-deprivation therapy.

Izumi K, Mizokami A, Sugimoto K, Narimoto K, Miwa S, Maeda Y, Kadono Y, Takashima M, Koh E, Namiki M. Izumi K, et al. Among authors: mizokami a. Urology. 2009 Jun;73(6):1342-6. doi: 10.1016/j.urology.2009.01.046. Epub 2009 Apr 15. Urology. 2009. PMID: 19371939

4

Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.

Izumi K, Mizokami A, Li YQ, Narimoto K, Sugimoto K, Kadono Y, Kitagawa Y, Konaka H, Koh E, Keller ET, Namiki M. Izumi K, et al. Among authors: mizokami a. Prostate. 2009 Aug 1;69(11):1222-34. doi: 10.1002/pros.20975. Prostate. 2009. PMID: 19434660 Free article.

5

Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone.

Mizokami A, Koh E, Izumi K, Narimoto K, Takeda M, Honma S, Dai J, Keller ET, Namiki M. Mizokami A, et al. Endocr Relat Cancer. 2009 Dec;16(4):1139-55. doi: 10.1677/ERC-09-0070. Epub 2009 Jul 16. Endocr Relat Cancer. 2009. PMID: 19608712

6

CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer.

Li Y, Mizokami A, Izumi K, Narimoto K, Shima T, Zhang J, Dai J, Keller ET, Namiki M. Li Y, et al. Among authors: mizokami a. Prostate. 2010 Jan 1;70(1):48-60. doi: 10.1002/pros.21037. Prostate. 2010. PMID: 19725034 Free article.

7

A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy.

Miwa S, Mizokami A, Konaka H, Izumi K, Nohara T, Namiki M. Miwa S, et al. Among authors: mizokami a. Jpn J Clin Oncol. 2009 Nov;39(11):745-50. doi: 10.1093/jjco/hyp122. Epub 2009 Oct 6. Jpn J Clin Oncol. 2009. PMID: 19808839

8

Successful treatment for metastases from renal cell carcinoma with alternation of interferon-alpha subtypes.

Miwa S, Kadono Y, Sugata T, Mizokami A, Namiki M. Miwa S, et al. Among authors: mizokami a. Int J Clin Oncol. 2010 Feb;15(1):97-100. doi: 10.1007/s10147-009-0003-7. Int J Clin Oncol. 2010. PMID: 20066455

9

[Bone and Men's Health. Hormonal therapy and bone loss in prostate cancer].

Izumi K, Mizokami A, Namiki M. Izumi K, et al. Among authors: mizokami a. Clin Calcium. 2010 Feb;20(2):175-81. Clin Calcium. 2010. PMID: 20118508 Review. Japanese.

10

Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen.

Narimoto K, Mizokami A, Izumi K, Mihara S, Sawada K, Sugata T, Shimamura M, Miyazaki K, Nishino A, Namiki M. Narimoto K, et al. Among authors: mizokami a. Int J Urol. 2010 Apr;17(4):337-45. doi: 10.1111/j.1442-2042.2010.02473.x. Epub 2010 Mar 1. Int J Urol. 2010. PMID: 20202011 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

484 results

Search Page